Oliver Dorigo MD
General Obstetrics, Gynecologic Oncology, Reproductive Endocrinology & Infertility
Assistant Professor, Obstetrics & Gynecology, UCLA School of Medicine
Join to View Full Profile
300 Pasteur DrPalo Alto, CA 94305
Dr. Dorigo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Obstetrics and Gynecology, 1996 - 1999
Ruprecht Karl University Faculty of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1997 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
- Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer Start of enrollment: 2020 Mar 30
Publications & Presentations
PubMed
- Long term treatment of advanced endometrial cancer with lenvatinib and pembrolizumab.Sahana Somasegar, Becky Sousa Msn, Arati Jairam-Thodla, Oliver Dorigo
Gynecologic Oncology Reports. 2025-04-01 - Fertility-sparing treatment for atypical polypoid adenomyoma.Isabel Beshar, Susan Lang, Oliver Dorigo, Brooke E Howitt, Caroline Liu
Gynecologic Oncology Reports. 2025-04-01 - Presentation and Management of Highly Differentiated Follicular Carcinoma of Ovarian Origin WithGene Variants.Susan Seav, Mazen Atiq, Ying-Chun Lo, Jagruti Shah, Oliver Dorigo
JCEM Case Reports. 2024-12-01
Lectures
- To Infinity and Beyond: The Future of Immunotherapy in Gynecologic MalignanciesASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- Clinical data from the DeCidE1 trial: Assessing the first combination of DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with s...2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
Some Experts Say More Women Should Consider Removing Fallopian Tubes to Reduce Cancer RiskMarch 3rd, 2023- Women at High Risk of Ovarian Cancer Should Consider Fallopian Tube Removal, Experts SayMarch 3rd, 2023
- Ovarian Cancer: Can Removing Fallopian Tubes Decrease the Risk?February 3rd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
